Showing results (31-40 of 327) with videos related to
Sort By:
Pageof 33
Clinical Pharmacology and Therapeutics|January 1, 1982
Antipyrine disposition in milk and saliva of lactating womenC M Berlin, E S VesellFederation Proceedings|May 15, 1984
A new polymorphism of hepatic drug oxidation in humans: family studies of antipyrine metabolitesE S Vesell, M B PennoPharmacology|February 2, 1999
Studies on pyrazinoylguanidine. 7. Effects of single oral doses in normal human subjectsE S Vesell, K H BeyerClinical Pharmacology and Therapeutics|December 1, 1976
Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver diseaseG W Hepner, E S VesellPharmacology & Therapeutics|December 1, 1993
Variables affecting nicotine metabolismM J Seaton, E S VesellJournal of Clinical Pharmacology|December 1, 1999
Are the elderly underrepresented in clinical drug trials?D L Schmucker, E S VesellThe American Journal of Digestive Diseases|January 1, 1975
Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunctionG W Hepner, E S VesellBiochemical Pharmacology|February 15, 1989
Hormonal regulation of the developmental pattern of epoxide hydrolases. Studies in rat liverC L Denlinger, E S VesellActa Physiologica, Pharmacologica Et Therapeutica Latinoamericana : Organo De La Asociacion Latinoamericana De Ciencias Fisiologicas Y [De] La Asociacion Latinoamericana De Farmacologia|January 1, 1994
Basal and paracetamol-depleted glutathione from human lymphocytes: ethnic variabilityF Estévez, T De Angelo, E S VesellScience (New York, N.Y.)|April 2, 1971
Lactate dehydrogenase isozymes: further kinetic studies at high enzyme concentrationT Wuntch, R F Chen, E S VesellPageof 33